Results 211 to 220 of about 519,396 (228)
Some of the next articles are maybe not open access.
Vaccine, 2009
During the period March 1, 1998 to January 14, 2007, approximately 6 million doses of Anthrax vaccine adsorbed (AVA) vaccine were administered. As of January 16, 2007, 4753 reports of adverse events following receipt of AVA vaccination had been submitted to the Vaccine Adverse Event Reporting System (VAERS).
Manette T, Niu +5 more
openaire +2 more sources
During the period March 1, 1998 to January 14, 2007, approximately 6 million doses of Anthrax vaccine adsorbed (AVA) vaccine were administered. As of January 16, 2007, 4753 reports of adverse events following receipt of AVA vaccination had been submitted to the Vaccine Adverse Event Reporting System (VAERS).
Manette T, Niu +5 more
openaire +2 more sources
[Adverse events and adverse event reporting systems].
Der Anaesthesist, 2008Knowledge about the incidence of errors in anaesthesia and intensive care is only rudimentary but it appears justified to assume that errors occur much more often than we all expect. One reason is most likely the complexity of our work. Errors may alter our patients' health and healing process, imply financial and legal personal and institutional ...
M, Hübler +3 more
openaire +1 more source
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of
ObjectivesDupilumab was the first biologic approved to treat chronic rhinosinusitis with nasal polyps (CRSwNP). While the risk of adverse events in phase‐III clinical trials was low, dupilumab‐associated adverse reactions (DAR) with real‐world use is unknown and potentially under‐reported. We aimed to evaluate DAR for CRSwNP treatment (CRSwNP‐tx) using
Austin R. Swisher +3 more
openaire +2 more sources
Misinformation and the Vaccine Adverse Event Reporting System
JAMAThis Viewpoint posits that to improve public understanding of the system, the Vaccine Adverse Event Reporting System (VAERS) could use a more accurate name, well-defined guidance about the reporting system’s nature and use, and comprehensible information about an event’s verification status.
Kathleen Hall, Jamieson +2 more
openaire +2 more sources
New Adverse Event Reporting System Enhances Value, Scope
Biomedical Instrumentation & Technology, 2008The continuous renal replacement therapy (CRRT) systems at The Methodist Hospital in Houston, TX, were generally known to be difficult to use. “We were aware of anecdotal reports of problems with the systems, but couldn’t justify the replacement of the expensive equipment without more substantial evidence,” says Marc Bateman, a clinical engineer on ...
openaire +2 more sources
International Journal of Obesity, 2016
Use of antiobesity medicines has been linked with serious cardiac and psychiatric adverse events (AEs). Spontaneous reports can provide information about serious, rare and unknown AEs occurring after the time of marketing. In Europe, information about AEs reported for antiobesity medicines can be accessed in the EudraVigilance (EV) database. Therefore,
Aagaard, L, Hallgreen, C E, Hansen, E H
openaire +4 more sources
Use of antiobesity medicines has been linked with serious cardiac and psychiatric adverse events (AEs). Spontaneous reports can provide information about serious, rare and unknown AEs occurring after the time of marketing. In Europe, information about AEs reported for antiobesity medicines can be accessed in the EudraVigilance (EV) database. Therefore,
Aagaard, L, Hallgreen, C E, Hansen, E H
openaire +4 more sources
Expert Opinion on Drug Safety
Leuprorelin, a gonadotropin-releasing hormone agonist, is widely used to treat hormone-related disorders. This study aims to explore and analyze the safety profile of leuprorelin by examining adverse event reports from the FDA Adverse Event Reporting System (FAERS) database.This study conducted a retrospective pharmacovigilance analysis using FAERS ...
Xiao, Tang +4 more
openaire +2 more sources
Leuprorelin, a gonadotropin-releasing hormone agonist, is widely used to treat hormone-related disorders. This study aims to explore and analyze the safety profile of leuprorelin by examining adverse event reports from the FDA Adverse Event Reporting System (FAERS) database.This study conducted a retrospective pharmacovigilance analysis using FAERS ...
Xiao, Tang +4 more
openaire +2 more sources
Journal of Clinical Pharmacy and Therapeutics, 2018
Pregabalin is used for neuropathic and postherpetic pain and generalized anxiety. The aim of this study was to obtain the onset profiles of adverse events (AE) related to falls (AEFs) such as "somnolence," "dizziness," "loss of consciousness" and "fall" onset and several clinical factor combinations such as age and administered dose, using spontaneous ...
Ririka Mukai +9 more
openaire +2 more sources
Pregabalin is used for neuropathic and postherpetic pain and generalized anxiety. The aim of this study was to obtain the onset profiles of adverse events (AE) related to falls (AEFs) such as "somnolence," "dizziness," "loss of consciousness" and "fall" onset and several clinical factor combinations such as age and administered dose, using spontaneous ...
Ririka Mukai +9 more
openaire +2 more sources
Asian Journal of Psychiatry, 2017
Signal detection is one of the most advanced and emerging field in pharmacovigilance. It is a modern method of detecting new reaction (which can be desired or undesired) of a drug. It facilitates early adverse drug reaction detection which enables health professionals to identify adverse events that may not have been identified in pre-marketing ...
Viswam, Subeesh +3 more
openaire +2 more sources
Signal detection is one of the most advanced and emerging field in pharmacovigilance. It is a modern method of detecting new reaction (which can be desired or undesired) of a drug. It facilitates early adverse drug reaction detection which enables health professionals to identify adverse events that may not have been identified in pre-marketing ...
Viswam, Subeesh +3 more
openaire +2 more sources
Urology Practice
Medical misinformation regarding COVID-19 immunization remains rampant and a public concern, and as such, there is a need for national studies evaluating the immunization's safety profile. We sought to quantify and analyze urologic adverse events and symptoms after COVID-19 immunization, compare these events reported between COVID-19 vaccine types, and
Owais M. Aftab +7 more
openaire +2 more sources
Medical misinformation regarding COVID-19 immunization remains rampant and a public concern, and as such, there is a need for national studies evaluating the immunization's safety profile. We sought to quantify and analyze urologic adverse events and symptoms after COVID-19 immunization, compare these events reported between COVID-19 vaccine types, and
Owais M. Aftab +7 more
openaire +2 more sources

